peHUB Second Opinion
In Second Opinion, NPS Pharmaceuticals hires Goldman Sachs to find a buyer, don't expect many mega IPOs in 2015 and it's very cold in Chicago right now.
6 January 2015•1 min read
In Second Opinion, NPS Pharmaceuticals hires Goldman Sachs to find a buyer, don't expect many mega IPOs in 2015 and it's very cold in Chicago right now.
